Evidence map›Paper›PMID 35783528›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

The Efficacy and Safety of Xinjia Xuanbai Chengqi Granules in Acute Exacerbation of COPD: A Multicentre, Randomised, Double-Blind, Controlled Trial.

Ruihan Qi, Hongchun Zhang, Demin Li, Feng Gao, Qing Miao, Sheng Chen, Yan Huang, Lei Wu, Zhenhui Lu, Haibo Hu and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 1 country.

Ruihan QiDepartment of Respiratory and Critical Care Medicine, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen 518033, China.ORCID https://orcid.org/0000-0001-6267-7349
Hongchun ZhangCenter of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.ORCID https://orcid.org/0000-0001-7390-6995
Demin LiCenter of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.ORCID https://orcid.org/0000-0002-4009-2048
Feng GaoDepartment of Respiratory Medicine, Wang Jing Hospital of CACMS, Beijing 100102, China.ORCID https://orcid.org/0000-0002-0237-5004
Qing MiaoDepartment of Pulmonary Disease, Xiyuan Hospital of CACMS, Beijing 100091, China.ORCID https://orcid.org/0000-0003-1571-8106
Sheng ChenDepartment of Respiratory and Critical Care Medicine, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen 518033, China.ORCID https://orcid.org/0000-0002-6820-1998
Yan HuangDepartment of Pulmonary Disease, Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine, Hohhot 750306, China.ORCID https://orcid.org/0000-0002-7641-7203
Lei WuDepartment of Respiratory Medicine II, Hebei Hospital of Traditional Chinese Medicine, Shijiazhuang 050011, China.ORCID https://orcid.org/0000-0002-2250-423X
Zhenhui LuRespiratory Research Institute of Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.ORCID https://orcid.org/0000-0002-7172-6621
Haibo HuDepartment of Respiratory and Critical Care Medicine, Qingdao Haici Medical Group, Qingdao 266033, China.ORCID https://orcid.org/0000-0002-7063-1997
Erran LiDepartment of Respiratory and Critical Care Medicine, The First Hospital of China Medical University, Shenyang 110002, China.ORCID https://orcid.org/0000-0001-6393-0764
Zhibin ChenDepartment of Respiratory Medicine, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350002, China.ORCID https://orcid.org/0000-0001-8403-1258
China-Japan Friendship Hospital · CNShenzhen Pingle Orthopedic Hospital · CNFirst Hospital of China Medical University · CNFujian University of Traditional Chinese Medicine · CNHaier Group (China) · CNHospital of Hebei Province · CNInner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine · CNShanghai University of Traditional Chinese Medicine · CNWangjing Hospital of China Academy of Chinese Medical Sciences · CNXiyuan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The study aimed to explore the efficacy and safety of Xinjia Xuanbai Chengqi granules (XJXBCQ) combined with conventional medicine in the treatment of acute exacerbation of chronic pulmonary disease (AECOPD). Results: XJXBCQ adjunct with conventional treatment could significantly improve the total efficacy ( Conclusion: XJXBCQ is beneficial and safe for AECOPD treatment and could be considered an adjunctive therapy for promoting the relief of clinical symptoms. This trial is registered with ChiCTR1800016915.

Identifiers

PMID35783528
PMCPMC9246576
OpenAlexW4283375291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.